ABSTRACT The present work evaluated the immunomodulatory effect of thalidomide (Thal) at different doses on tumor-associated macrophages (TAMs) using a mouse model of human breast cancer. Mice were inoculated with 4T1 cells in the left flank and treated with Thal once a day at concentrations of 50. 100. and 150mg/kg body weight from the 5th day until the 28th day of tumor inoculation. https://www.chiggate.com/jerome-brown-philadelphia-eagles-mitchell-ness-1990-legacy-jersey-discount/